Skip to main content
HEM Pharma Inc. logo

HEM Pharma Inc. — Investor Relations & Filings

Ticker · 376270 ISIN · KR7376270005 KO Manufacturing
Open in API
Filings indexed 93 across all filing types
Latest filing 2025-08-26 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 376270

About HEM Pharma Inc.

https://hempharma.bio/

HEM Pharma Inc. is a biotechnology company specializing in microbiome-based healthcare solutions. The company researches and develops Live Biotherapeutic Products (LBPs), health functional foods, and other bio-products derived from human-effective microbes. A core component of its R&D is the proprietary Pharmaceutical Meta-Analysis System (PMAS), a technology platform that simulates the human gut microbiome to screen for and analyze beneficial microorganisms. In addition to its product pipeline, HEM Pharma provides personalized healthcare services based on microbiome analysis and offers Contract Development and Manufacturing Organization (CDMO) services for next-generation biological materials.

Recent filings

Filing Released Lang Actions
반기보고서 (2025.06)
Interim / Quarterly Report Classification · 1% confidence The document is a '반기보고서' (Semi-Annual Report) for the company '주식회사 에이치이엠파마' (HEM Pharma Inc.) covering the period from January 1, 2025, to June 30, 2025. It contains detailed financial information, business operations, management discussions, and corporate governance details, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2025
2025-08-26 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean regulatory authorities (Financial Supervisory Service/Korea Exchange). This type of filing is a standard disclosure for insider trading or changes in share ownership by company directors or major shareholders. According to the provided definitions, 'Director's Dealing' (DIRS) is the correct category for reports of personal share transactions by company directors and executives.
2025-06-26 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard regulatory filing in South Korea (often referred to as an 'Insider Trading Report' or 'Director's Dealing') where company executives or major shareholders disclose changes in their shareholdings. Based on the provided categories, this fits the 'Director's Dealing' (DIRS) classification.
2025-06-18 Korean
분기보고서 (2025.03)
Interim / Quarterly Report Classification · 1% confidence The document is a '분기보고서' (Quarterly Report) for the company '주식회사 에이치이엠파마' (HEM Pharma Inc.) covering the period from 2025-01-01 to 2025-03-31. It contains detailed sections on company overview, business operations, capital structure, and financial information, which is characteristic of a formal quarterly financial report. It is not a mere announcement or certification, but the full report itself. Q1 2025
2025-05-21 Korean
임시주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled '임시주주총회결과' (Extraordinary General Meeting Results) and provides the outcome of specific agenda items (voting results) from a shareholder meeting held on 2025-05-08. This aligns perfectly with the definition for Declaration of Voting Results & Voting Rights Announcements.
2025-05-08 Korean
주주총회소집공고
AGM Information Classification · 1% confidence The document is a 'Notice of Extraordinary General Meeting of Shareholders' (주주총회소집공고) for HEM Pharma. It contains the meeting agenda, date, location, and detailed management information including board activity, remuneration, and business overview. This document is a formal proxy statement/notice sent to shareholders to inform them of an upcoming meeting and provide necessary background information for voting, which fits the definition of a Proxy Solicitation & Information Statement.
2025-04-23 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.